DR. DAVID J. ORRINGER MD NPI 1275503328

NPI Details

DR. David J. Orringer, MD is a general practice in Tucson, AZ. The provider is a physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions. Source: National Uniform Claim Committee DR. David J. Orringer, MD NPI is 1275503328. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

310 N WILMOT RD
STE 206
TUCSON, AZ
ZIP 85711-627
Phone: (520) 372-8292
Fax: (520) 372-8444

The NPI 1275503328 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0220)
• Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique (HCPCS:87634)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Detection test by immunoassay technique for influenza virus (HCPCS:87400)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 1/23/2006 and was last updated on 4/9/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: